Vifor Pharma AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vifor Pharma AG with three other
pharmaceutical manufacturers in Europe:
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
sales of 445.48 billion Hungarian Forints [US$1.49 billion]
of which 80%
was Pharmaceutical Manufacturing and Sale),
(1.35 billion Euro [US$1.50 billion]
of which 84%
was Specialty & Primary care), and
Krka DD Novo Mesto
based in Slovenia
(1.33 billion Euro [US$1.47 billion]
of which 60%
was European Union).
During the year ended December of 2018, sales at
Vifor Pharma AG were 1.58 billion Swiss Francs (US$1.60 billion).
increase of 18.1%
versus 2017, when the company's sales were 1.34 billion Swiss Francs.
Despite this increase, sales are still
below the level achieved in 2016, when Vifor Pharma AG
reported sales of 4.12 billion Swiss Francs.